Search
Increased dose of Eylea to extend treatment intervals
Latest news, posted 1 March 2024
Renowned retinal specialist Dr Kenneth Fan has called the higher approved dose of Eylea for patients with wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO), “a pivotal moment” for the treatment of these conditions.
Encouraging results from light therapy study for dry AMD
Latest news, posted 1 March 2024
Early results from a study assessing the effectiveness of the Valeda Light Delivery System for treating dry age-related macular degeneration (AMD), have shown promise.
Enquiry explores employers’ attitudes to visually impaired employees
Latest news, posted 5 March 2024
The All Party Parliamentary Group (APPG) on Eye Health and Visual Impairment has launched an enquiry to find out more about how employers treat and hire blind and partially sighted people.
All you need to know about implantable magnifying lenses for macular disease
Latest news, posted 25 March 2024
Intraocular lenses (IOLs) were the focus of our My Macular and Me webinar in March, as Dr Julie Silvestri shed light on the potential of these devices, which aim to improve vision for people living with sight loss.
‘Regular injections essential in maintaining vision’
Latest news, posted 27 March 2024
Early diagnosis, prompt initial treatment, and regular injections help stabilise vision in most eyes with wet age-related macular degeneration (AMD), according to a new report published by the Royal College of Ophthalmologists
'It's very important that I make the best of what I can see and do now'
Latest news, posted 25 April 2024
John has been creative for as long as he can remember, and is determined to keep doing what he loves, while adjusting to life with sight loss.
Macular Society partners with UK’s largest health research programme
Latest news, posted 5 April 2024
The Macular Society is proud to announce a new partnership with Our Future Health, a groundbreaking initiative aimed at revolutionising research into health conditions such as age-related macular degeneration (AMD).
Home monitoring for patients with AMD
Latest news, posted 3 April 2024
Health tech startup OKKO Health has shared new insights from its UK research study on home monitoring for age-related macular degeneration (AMD). The study is being carried out in collaboration with the Macular Society.
Discover the latest news on treatments and emerging drugs
Latest news, posted 2 April 2024
A webinar exploring the fast-changing landscape of treatments for age-related macular degeneration (AMD) will be hosted by OcuPlan this month.
New study identifies 87 genes linked to AMD
Latest news, posted 26 April 2024
Researchers at the National Eye Institute in the USA have discovered 87 genes in retinal cells that could be affected by environmental factors which may influence the risk of developing age-related macular degeneration (AMD).